Frontiers in Nutrition (Jul 2022)
A Novel Systemic Inflammation Prognostic Score to Stratify Survival in Elderly Patients With Cancer
- Guo-Tian Ruan,
- Guo-Tian Ruan,
- Guo-Tian Ruan,
- Hai-Lun Xie,
- Hai-Lun Xie,
- Hai-Lun Xie,
- Li Deng,
- Li Deng,
- Li Deng,
- Yi-Zhong Ge,
- Yi-Zhong Ge,
- Yi-Zhong Ge,
- Qi Zhang,
- Qi Zhang,
- Qi Zhang,
- Zi-Wen Wang,
- Zi-Wen Wang,
- Zi-Wen Wang,
- Xi Zhang,
- Xi Zhang,
- Xi Zhang,
- He-Yang Zhang,
- He-Yang Zhang,
- He-Yang Zhang,
- Meng Tang,
- Meng Tang,
- Meng Tang,
- Meng-Meng Song,
- Meng-Meng Song,
- Meng-Meng Song,
- Xiao-Wei Zhang,
- Xiao-Wei Zhang,
- Xiao-Wei Zhang,
- Ming Yang,
- Ming Yang,
- Ming Yang,
- Lei Pan,
- Kun-Hua Wang,
- Kun-Hua Wang,
- Ming-Hua Cong,
- Yi-Zhen Gong,
- Yi-Zhen Gong,
- Meng-Yan Wang,
- Han-Ping Shi,
- Han-Ping Shi,
- Han-Ping Shi
Affiliations
- Guo-Tian Ruan
- Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Guo-Tian Ruan
- Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Guo-Tian Ruan
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Hai-Lun Xie
- Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Hai-Lun Xie
- Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Hai-Lun Xie
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Li Deng
- Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Li Deng
- Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Li Deng
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Yi-Zhong Ge
- Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Yi-Zhong Ge
- Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Yi-Zhong Ge
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Qi Zhang
- Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Qi Zhang
- Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Qi Zhang
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Zi-Wen Wang
- Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Zi-Wen Wang
- Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Zi-Wen Wang
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Xi Zhang
- Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Xi Zhang
- Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Xi Zhang
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- He-Yang Zhang
- Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- He-Yang Zhang
- Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- He-Yang Zhang
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Meng Tang
- Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Meng Tang
- Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Meng Tang
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Meng-Meng Song
- Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Meng-Meng Song
- Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Meng-Meng Song
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Xiao-Wei Zhang
- Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Xiao-Wei Zhang
- Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Xiao-Wei Zhang
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Ming Yang
- Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Ming Yang
- Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Ming Yang
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- Lei Pan
- Department of Respiratory and Critical Care Medicine, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Kun-Hua Wang
- Yunnan University, Kunming, China
- Kun-Hua Wang
- General Surgery Clinical Medical Center of Yunnan Province, Kunming, China
- Ming-Hua Cong
- Comprehensive Oncology Department, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Yi-Zhen Gong
- Department of Gastrointestinal Surgery, Guangxi Medical University Cancer Hospital, Nanning, China
- Yi-Zhen Gong
- Guangxi Clinical Research Center for Colorectal Cancer, Nanning, China
- Meng-Yan Wang
- 0Department of General Surgery, The 906th Hospital of the Joint Logistics Support Force of the Chinese People’s Liberation Army, Ningbo, China
- Han-Ping Shi
- Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Han-Ping Shi
- Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
- Han-Ping Shi
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China
- DOI
- https://doi.org/10.3389/fnut.2022.893753
- Journal volume & issue
-
Vol. 9
Abstract
BackgroundElderly patients with cancer face the challenge of systemic inflammation, which can lead to a poor prognosis. Existing inflammatory indices cannot fully reflect the immune-inflammatory status of patients. This study aimed to develop a new scoring system to predict the survival of elderly patients with cancer using inflammatory indices, namely, the systemic inflammation prognostic score (SIPS).Materials and MethodsThis prospective multicenter study included a total of 1,767 patients with cancer, with a mean age of 70.97 ± 5.49 years, of whom 1,170 (66.2%) were men. We performed the least absolute shrinkage and selection operator (LASSO) regression to screen inflammatory indicators to include in constructing SIPS. Prognostic analysis of SIPS was performed using univariate and multivariate survival analyzes. The prognostic value of SIPS and its components were compared using the prognostic receiver operating characteristic curve and concordance index. The population was divided into the training cohort and the validation cohort in a 7:3 ratio and a SIPS prognostic analysis was performed.ResultsThe LASSO regression selected C-reactive protein (CRP) (≤ 9.81, “0”; > 9.81, “1”), geriatric nutritional risk index (GNRI) (≤ 93.85, “1”; 93.85, “0”), advanced lung cancer inflammation index (ALI) (≤ 23.49, “1”; > 23.49, “0”), and lymphocyte to C-reactive protein ratio (LCR) (≤ 2523.81, “1”; > 2523.81, “0”) to develop SIPS. Patients were divided into the three groups based on the total SIPS: low-risk (0), moderate-risk (1–2), and high-risk (3–4). On the multivariate survival analysis, patients in the moderate-risk [P < 0.001, hazard ratio (HR) = 1.79, 95% CI: 1.47–2.17] and high-risk groups (P < 0.001, HR = 2.40, 95% CI: 1.98–2.92) showed a worse prognosis than those in the low-risk group. The total cohort, training cohort, and validation cohort all showed that SIPS had better survival prediction than CRP, GNRI, ALI, and LCR. The HRs were 2.81 times higher in patients in the high-risk group with malnutrition than in patients in the low-risk group without malnutrition.ConclusionSIPS was an independent prognostic indicator in elderly patients with cancer. Malnutrition in the high-risk group increased the mortality risk.
Keywords